- Home
- WTBA vs CLLS Comparison
WTBA vs CLLS Comparison
Compare WTBA & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | CLLS |
|---|---|---|
| Founded | 1893 | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.0M | 299.0M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | WTBA | CLLS |
|---|---|---|
| Price | $22.15 | $4.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $23.50 | $8.00 |
| AVG Volume (30 Days) | 28.3K | ★ 137.4K |
| Earning Date | 01-22-2026 | 11-07-2025 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | ★ 49.53 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $91,783,000.00 | $82,551,000.00 |
| Revenue This Year | $25.05 | $32.58 |
| Revenue Next Year | $10.87 | N/A |
| P/E Ratio | $11.76 | ★ N/A |
| Revenue Growth | 19.66 | ★ 129.04 |
| 52 Week Low | $17.31 | $1.10 |
| 52 Week High | $24.16 | $5.48 |
Technical Indicators
Market Signals| Indicator | WTBA | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 56.19 | 58.54 |
| Support Level | $21.91 | $4.52 |
| Resistance Level | $22.75 | $4.92 |
| Average True Range (ATR) | 0.50 | 0.29 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 70.08 | 56.90 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.